Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Oct 22;14(1):24884.
doi: 10.1038/s41598-024-76896-8.

Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies

Affiliations
Meta-Analysis

Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies

Agnieszka Drab et al. Sci Rep. .

Abstract

Endometrial cancer is one of the most common gynaecological cancers in the developed countries. The aim of this study was to determine the impact of hypertension on endometrial cancer risk. Databases: PubMed, Embase and the Cochrane Library were searched from January 2000 to June 2024. We used DerSimonian-Laird random-effects model for analysis. Risk estimates were extracted by two authors and summarized using meta-analytic methods. A total of 26 observational studies with 207,502 endometrial cancer cases were included in the study. Overall meta-analysis demonstrates significant association between hypertension and endometrial cancer risk (RR = 1.37, 95% CI: 1.27-1.47, p < 0.001). Subgroup analysis of the risk of endometrial cancer shows statistically significant higher risk in patients with BMI ≥ 30 kg/m2, diabetics, women who had their first menstrual period at the age of 11 years or earlier, and who had never given birth. Findings of this comprehensive review and meta-analysis indicate that hypertension is associated with higher overall risk of endometrial cancer.

Keywords: Endometrial cancer; Endometrial carcinoma; Gynecologic oncology; Hypertension; Meta-analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the selection procedure for studies included in the review and meta-analysis.
Fig. 2
Fig. 2
Forest plot of meta-analysis hypertension and endometrial cancer risk.

References

    1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 399 (10324), 520. 10.1016/S0140-6736(21)01330-1 (2022). - PMC - PubMed
    1. Kario, K. et al. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens. Res.47, 1099–1102. 10.1038/s41440-024-01622-w (2024). - PubMed
    1. Boateng, E. B. & Ampofo, A. G. A glimpse into the future: modelling global prevalence of hypertension. BMC public health. 23(1), 1906. (2023). 10.1186/s12889-023-16662-z - PMC - PubMed
    1. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study. Lancet. 396 (10258), 1223–1249. 10.1016/S0140-6736(20)30752-2 (2020). - PMC - PubMed
    1. Jia, G., Sowers, J. R. & Whaley-Connell, A. Obesity in hypertension: the role of the Expanding Waistline over the years and insights into the future. Hypertension. 81(4), 687–690. 10.1161/hypertensionaha.123.21719 (2024). - PMC - PubMed

Publication types

LinkOut - more resources